PhaBuilder
A company with leading synthetic biotechnology, focusing on the transformation and engineering of halophilic microorganisms.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD269—404m (Dealroom.co estimates Feb 2023.)
Shunyi District Beijing (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
CNY50.0m | Seed | ||
* | CNY250m | Series A | |
* | CNY95.0m Valuation: CNY1.3b | Series A | |
* | CNY359m | Series A | |
Total Funding | CAD141m |